CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced the presentation of preclinical data at the American Society of Clinical Oncology Annual Meeting being held June 1 through June 5, 2012, in Chicago, IL.
